Zhejiang Hisoar Pharmaceutical (002099.SZ) Earnings Analysis
Zhejiang Hisoar Pharmaceutical (002099.SZ) has no confirmed upcoming earnings date. Trailing P/E 376.47.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002099.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 002099.SZ. This page updates as the calendar is published.
002099.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-10-31 | -0.0165 CNY | n/a | n/a | n/a |
| 2024-08-31 | 0.0034 CNY | n/a | n/a | n/a |
002099.SZ valuation and analyst view
| Trailing P/E | 376.47 |
|---|---|
| Trailing EPS | -0.04721 CNY |
| Price / book | 1.62 |
| Dividend yield | 0.00% |
| Market cap | 8.06B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zhejiang Hisoar Pharmaceutical (002099.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 002099.SZ. This page updates as the calendar is published.
Did 002099.SZ beat earnings last quarter?
Consensus estimate data was not available for 002099.SZ's 2024-10-31 report.
What is 002099.SZ's current P/E ratio and EPS?
002099.SZ trades at a trailing P/E of 376.47 on trailing EPS of -0.047209299773912444 CNY.
What do analysts rate 002099.SZ?
002099.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.